Kraig Biocraft Laboratories Confirms Strength and Toughness of Its Commercially Produced Recombinant Spider Silk
ANN ARBOR, Mich., Aug. 13, 2024 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (“the Company” or “Kraig Labs”), announces today that it has confirmed that the material performance of its commercially produced recombinant spider silk matches the exceptional strength and toughness of the Company’s previous small batch performance testing. The results of this testing open the doors for Kraig Labs to aggressively move forward with commercial production of its proprietary recombinant spider silk.
Related news for (KBLB)
- Innovation Threads Drive Microcap Momentum
- Sportswear and Smart Textiles are likely Key Spider Silk Target Markets for Kraig Labs
- Bitcoin, Biotech, and Biosteel: Innovation Powers the Opening Bell
- Silk, Cells, and Sudden Swings
- Kraig Labs Offers Safer, Natural Alternative to Health Risks from Nylon and Polyester Clothing